← Back to headlines
UBS and Jefferies Downgrade Medtronic (MDT) Amid Diabetes Unit Restructuring
UBS and Jefferies have lowered their outlooks on Medtronic (MDT) following changes within the company's diabetes unit.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
